SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of
Date of Report (Date of earliest event reported): April 16, 2012
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
300 N. Continental, Suite 100,
El Segundo California
|(Address of principal executive offices)
Registrants telephone number, including area code: (310) 615-1900
(Former name or former address, if changed since last report.)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
The information in this Current Report on Form 8-K and the exhibit hereto is being furnished and shall not
be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly
set forth by specific reference in such filing.
Item 2.02 Results of Operations and Financial Condition.
On April 16, 2012, Cereplast, Inc. issued a press release announcing its financial results for the year ended December 31, 2011. The Company
also held a conference call discussing such results and outlook on April 16, 2012 at 4:30 p.m. (EST). The full text of the press release is attached hereto as Exhibit 99.1.
99.1 Press Release dated April 16, 2012
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: April 16, 2012
|/s/ Frederic Scheer|
|Chief Executive Officer|